Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

T2 Biosystems Sells Four T2Dx Instruments To Existing European Distributor; Amount Not Disclosed

Author: Benzinga Newsdesk | December 18, 2024 10:04am

The multiple instrument sale demonstrates commercial expansion to enable increased utilization of the T2Bacteria® Panel, the T2Candida® Panel, and the T2Resistance® Panel. The target hospitals for the new instruments include:

  • Selling a second T2Dx Instrument to a major reference hospital to expand "same store" sales;
  • Selling the first T2Dx Instrument to a hospital in a country for initial market penetration; and
  • Selling two T2Dx Instruments to hospitals in countries that already utilize T2 Biosystems' products.
     

Posted In: TTOO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist